Kidney Stone Management Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Kidney Stone Management Market was valued at approximately USD 2.6 billion in 2023 and is projected to grow to around USD 4.1 billion by 2032, with a CAGR of 5.1%. This growth is largely driven by the increasing prevalence of kidney stones, their high recurrence rates, and the ongoing development of advanced technological solutions for treatment. Kidney stones, which can cause significant pain as they move through the urinary tract, are becoming more common due to aging populations and lifestyle factors, such as diets high in salt, protein, and oxalates.

Kidney stone management involves a range of medical treatments, diagnostic tools, and preventative strategies aimed at reducing stone formation. The market is segmented by stone type, with calcium oxalate stones being the most prevalent, representing 75-80% of cases. In 2023, the calcium oxalate segment generated USD 1.9 billion in revenue. Risk factors for these stones include diets rich in oxalates, such as spinach and nuts, along with high calcium intake.

Diagnostics in this market include abdominal x-rays, CT scans, ultrasounds, MRIs, and intravenous pyelography. CT scans led the market in 2023, and their popularity is expected to continue growing, with a projected market value of USD 1.3 billion by 2032. The appeal of CT scans lies in their rapid, non-invasive nature, making them particularly useful in emergency settings.

Treatment methods for kidney stones include extracorporeal shock wave lithotripsy (ESWL), ureteroscopy, and percutaneous nephrolithotomy (PCNL). ESWL dominated the market in 2023, accounting for 58.2% of the market share. This non-invasive technique uses shock waves to break down stones for easier passage and is especially effective for stones like calcium oxalate and uric acid.

Hospitals were the largest end use rs in the kidney stone management market, generating USD 1.3 billion in 2023. Hospitals are equipped to handle emergencies such as acute renal colic and offer advanced technologies, such as laser lithotripters and surgical robots, which are key drivers for this segment.

Regionally, North America led the market in 2023 with a value of USD 1.1 billion. The region's high prevalence of kidney stones is attributed to dietary and lifestyle factors. Additionally, the region's advanced healthcare infrastructure supports comprehensive kidney stone management.

Product Code: 2603

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence and recurrence rate of kidney stones globally
  - 3.2.1.2 Advancements in ureteroscopy technique
  - 3.2.1.3 Favourable reimbursement for lithotripsy procedures
  - 3.2.1.4 Inclination towards undergoing minimally invasive surgeries
  - 3.2.1.5 Rising awareness regarding overall kidney health
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Lack of treatment awareness in certain countries
  - 3.2.2.2 Potential long-term adverse effects of lithotripsy
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.7 Reimbursement scenario
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Calcium oxalate
5.3 Calcium phosphate
5.4 Uric acid
5.5 Struvite
5.6 Cysteine

Chapter 6 Market Estimates and Forecast, By Diagnostics, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Abdominal x-ray
6.3 Computed tomography
6.4 Ultrasound
6.5 Abdominal MRI
6.6 Intravenous pyelography
6.7 Other diagnostics

Chapter 7 Market Estimates and Forecast, By Treatment, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Abdominal x-ray
7.3 Extracorporeal shock wave lithotripsy (ESWL)
7.4 Ureteroscopy
7.5 Percutaneous nephrolithotomy (PCNL)
7.6 Other treatments

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Specialty clinics
8.4 Ambulatory surgical centers
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 Allengers Medical Systems Ltd
10.2 Becton, Dickinson and Company
10.3 Boston Scientific Corporation
10.4 Coloplast A/S
10.5 Cook Medical LLC
10.6 DirexGroup
10.7 Dornier MedTech
10.8 EDAP TMS S.A
10.9 Elmed Medical Systems
10.10 Karl Storz GmbH
10.11 Medispec Ltd
10.12 Olympus Corporation
10.13 Richard Wolf GmbH
10.14 Siemens Healthineers